BridgeMD
New treatment option for Obesity
Official title A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
ClinicalTrials.gov ID: NCT07595549
What this study is testing
What is PF-08653944?
PF-08653944 is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for obesity.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this clinical study is to learn about the effects and safety of berobenatide (PF-08653944). This may help people with overweight or obesity lose weight.
- Phase 3: a large, late-stage study
- Time commitment: about 20 months
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged ≥18 years.
- BMI of: ≥30 kg/m2 or ≥27.0 kg/m2 to \<30.0 kg/m2 and must have at least 1 of the following weight-related co-morbidities: hypertension, dyslipidemia...
You likely can't join if
- Have a self-reported body weight change greater than 5% within 90 days prior to Screening.
- Diagnosis of type 1 diabetes or any other form of diabetes other than T2D.
- History of acute or chronic pancreatitis.
- Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN-2).
The study team makes the final eligibility decision.
Where it's taking place
- Modesto, California, United States
- Roseville, California, United States
- Sacramento, California, United States
- Tustin, California, United States
- Walnut Creek, California, United States
- Crystal River, Florida, United States
- Lecanto, Florida, United States
- Miramar, Florida, United States
- New Port Richey, Florida, United States
- Evansville, Indiana, United States
- Louisville, Kentucky, United States
- Flint, Michigan, United States
- Albuquerque, New Mexico, United States
- Rochester, New York, United States
- Greensboro, North Carolina, United States
- Cincinnati, Ohio, United States
- San Antonio, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 20 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Modesto, California, United States; Roseville, California, United States; Sacramento, California, United States; Tustin, California, United States; Walnut Creek, California, United States; Crystal River, Florida, United States and 11 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.